A novel therapy for the treatment of pyoderma gangrenosum

Medical Journal of Malaysia

Volumn 63, Issue 1, 2008, Pages 51-54

  Azizan, Noor Zalmy ^a   Gangaram, H B ^a   Hussein, S H ^a  

^a HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; MINOCYCLINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TRIAMCINOLONE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PYODERMA GANGRENOSUM; SKIN BIOPSY; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; ADULT; CYCLOSPORINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PYODERMA GANGRENOSUM;

EID: 49649118233     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Brunsting LA, Goeckerman WH, O' Leary PA. Pyoderma gangrenosum: clinical and experimental observations in five cases occuring in adults. Arch Dermatol 1930; 22: 65S-80.
2. Curley R.K., Macfarlane A.W. Pyoderma gangrenosum treated with cyclosporine. Br J Dermatol 1985; 113: 601-604.
3. Powell FC, So WPD et al. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996; 34: 395-409.
4. Powell FC, Collins S. Pyoderma gangrenosum.Clinics in Dermatol. 2000; 18: 283-93.
5. Chow RKP, Ho VC. Treatment of pyoderma gangrenosurn J Am Acad Dermatol 1996; 34: 1047-60.
6. Eichhorn PJ. Pyoderma gangrenosum. Dermatol Therapy 2001; 14: 102-10.
7. Reichrath J, Bens G, Bonowitz A. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005; 53: 273-83.
8. O'Donnell B, Powell FC. Cyclosporine treatment of pyoderma gangrenosum. J Am Acad Dermatol 1991; 24: 141-3.
9. Matis W, Ellis CN, Griffiths CEM. Treatment of pyoderma gangrenosum with cyclosporine Arch Dermatol 1992; 128: 1060-64.
10. Mroweitz U, Christophers E. Clearing of pyoderma gangrenosum by intralesional cyclosporine. Br J Dermatol 1991; 125: 499.
11. Eisen D, Ellis C. Topical cyclosporine for oral disorders. J Am Acad Dermatol 1990; 23: 1259-64.
12. Schuppe HC, Homey B et al. Topical tacrolimus for pyoderma gangrenosum. Lancet 1998; 351: 832.
13. Ghislain PD, Decker ID, Marot L, Lachapelle JM. Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum. Br J Dermatol 2004; 150: 1052-53.
14. Kontos AF, Kerr HA, Fivenson D, Remishofsky C, Jacobsen G. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum. Int J Dermatol 2006; 45: 1383-85.
15. Richter-Hintz D, Schuppe HC et al. Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol 2000; 42: 304.
16. Gupta AK. Tacrolimus:a review of its use for the management of dermatoses. J Europ Acad Dermatol Venerol 2002; 16: 100-14.
17. Ho VC, Griffifths CEM, Ellis CN et al. Intralesional cyclosporine in the treatment of psoriasis. J Am Acad Dermatol 1990; 22: 94-100.